Over the years, Biosfer has continued to focus on innovation and constant development. This has enabled the company to receive funding from institutions that support the development of competitive innovation projects. Because of this impulse, the company has managed to advance in the extraction of information from the NMR spectra, validating the use of NMR spectroscopy for the characterization of biofluids and biotissues in biomedical and clinical research environments, being able to offer a global MR metabolomics profiling that includes, in addition to lipoprotein profiling (Liposcale® test), glycoprotein profiling, characterization of the aqueous plasma metabolome (LMWM) and lipidome characterization.